Molecular Insight Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Molecular Insight Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. It has received 24 US government small-business research awards (SBIR/STTR) from health agencies, $13 million in total, most recently in 2012.
Molecular Insight Pharmaceuticals at a glance
What does Molecular Insight Pharmaceuticals do?
US government research funding
24 SBIR/STTR small-business research awards from US health agencies, $12.7 million in total (2003 to 2012).
Frequently asked questions about Molecular Insight Pharmaceuticals
Where is Molecular Insight Pharmaceuticals headquartered?
Molecular Insight Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Molecular Insight Pharmaceuticals do?
Molecular Insight Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences